French pharmaceutical company Aqemia has entered into a $140 million drug research agreement with Sanofi to use generative AI to design novel drug molecules

French pharmaceutical company Aqemia said in a statement that it has reached a multi-year research collaboration agreement worth up to $140 million with Sanofi. Aqemia will use its generative AI and deep physics algorithms and platforms to design novel drug molecules.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)